These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Activities of hypoxanthine-guanine phosphoribosyltransferase and adenine phosphoribosyltransferase in erythrocytes from patients with Down's syndrome. Tada K; Uesaki T; Isshiki G; Oura T Tohoku J Exp Med; 1972 Oct; 108(2):197-8. PubMed ID: 4265623 [No Abstract] [Full Text] [Related]
48. Properties of erythrocyte purine phosphoribosyltransferases in partial hypoxanthine-guanine phosphoribosyltransferase deficiency. Sperling O; Boer P; De Vries A Adv Exp Med Biol; 1973; 41():211-3. PubMed ID: 4791193 [No Abstract] [Full Text] [Related]
49. The role of xanthine oxidase in hyperuricemic states. Marcolongo R; Marinello E; Pompucci G; Pagani R Arthritis Rheum; 1974; 17(4):430-8. PubMed ID: 4855072 [No Abstract] [Full Text] [Related]
50. Clinical features of patients with the "partial" deficiency of the X-linked uricaciduria enzyme. Greene ML Arch Intern Med; 1972 Aug; 130(2):193-8. PubMed ID: 5050554 [No Abstract] [Full Text] [Related]
51. Adenine phosphoribosyltransferase deficiency: report of a second family. Fox IH; Kelley WN Adv Exp Med Biol; 1973; 41():319-26. PubMed ID: 4791204 [No Abstract] [Full Text] [Related]
53. Survey of serum uric acid concentration in an institutionalized mentally retarded population. Bland JH; Jarrett FA; Plunkett GE; Ravaris CL; Sylwester D Fed Proc; 1968; 27(4):1087-90. PubMed ID: 5658476 [No Abstract] [Full Text] [Related]
54. Metabolic defects of primary hyperuricemia and gout. Wyngaarden JB Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475 [No Abstract] [Full Text] [Related]
55. Gout with adenine phosphoribosyl transferase deficiency. Delbarre F; Auscher C; Amor B; de Gery A Adv Exp Med Biol; 1973; 41():333-9. PubMed ID: 4791206 [No Abstract] [Full Text] [Related]
56. A new disorder of purine metabolism with behavioral manifestations. Nyhan WL; James JA; Teberg AJ; Sweetman L; Nelson LG J Pediatr; 1969 Jan; 74(1):20-7. PubMed ID: 5782823 [No Abstract] [Full Text] [Related]
57. Azaguanine-resistance as a manifestation of a new form of metabolic overproduction of uric acid. Benke PJ; Herrick N Am J Med; 1972 Apr; 52(4):547-55. PubMed ID: 5017247 [No Abstract] [Full Text] [Related]
58. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)]. Delbarre F; Auscher C; de Gery A; Brouilhet H; Olivier JL Presse Med (1893); 1968 Dec; 76(49):2329. PubMed ID: 5737251 [No Abstract] [Full Text] [Related]
59. An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency. Kelley WN; Rosenbloom FM; Miller J; Seegmiller JE N Engl J Med; 1968 Feb; 278(6):287-93. PubMed ID: 5638346 [No Abstract] [Full Text] [Related]
60. Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase-deficient patients. Hershfield MS J Clin Invest; 1981 Mar; 67(3):696-701. PubMed ID: 6782120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]